GSK (GSK) News Today → My top 100 stocks… (From DTI) (Ad) Free GSK Stock Alerts $41.11 +0.20 (+0.49%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineScientists Can Now See Inside a Single Cancer Cellmsn.com - April 27 at 11:53 PMGSK plc (NYSE:GSK) Short Interest Up 52.2% in Aprilmarketbeat.com - April 27 at 5:20 PMGSK plc (NYSE:GSK) Shares Purchased by Provident Trust Co.marketbeat.com - April 27 at 3:43 PMSave The Children, GSK Launch $1m Immunisation Initiative For Nigeria, Ethiopiamsn.com - April 27 at 8:52 AMGlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyreuters.com - April 25 at 9:40 AMGSK Advocates Importance of Adult Immunisation amongst Malaysiansfinance.yahoo.com - April 25 at 8:38 AMCureVac Shares Touch All-Time Low After Germany Deal Ends, Redesign Newsmarketwatch.com - April 24 at 4:07 PM20,000 Shares in GSK plc (NYSE:GSK) Purchased by Cumberland Partners Ltdmarketbeat.com - April 24 at 3:52 PMGSK's Jemperli with chemotherapy accepted for priority review by FDAlse.co.uk - April 24 at 5:06 AMGSK : Jemperli Granted Priority Review By FDA For Expanded Use In Endometrial Cancer Treatmentmarkets.businessinsider.com - April 24 at 5:06 AMGSK (GSK) Set to Announce Quarterly Earnings on Wednesdayamericanbankingnews.com - April 24 at 1:58 AMUniversity of Toronto scientists appointed as GSK chairs will advance drug delivery research and vaccine education tools for healthcare professionalsca.finance.yahoo.com - April 23 at 2:05 PMStock Traders Purchase Large Volume of GSK Put Options (NYSE:GSK)americanbankingnews.com - April 23 at 1:06 AMGSK Sees Unusually Large Options Volume (NYSE:GSK)marketbeat.com - April 22 at 1:31 PMFoundry Partners LLC Sells 27,560 Shares of GSK plc (NYSE:GSK)marketbeat.com - April 21 at 10:44 PMKornitzer Capital Management Inc. KS Cuts Holdings in GSK plc (NYSE:GSK)marketbeat.com - April 20 at 11:18 AMGSK shingles vaccine shown 82% effective 11 years after vaccinationmsn.com - April 17 at 2:52 PMGSK: Phase III Data Shows Gepotidacin Potential For Uncomplicated Urogenital Gonorrhea Treatmentnasdaq.com - April 17 at 9:52 AMGSK Velu’s Neuberg Diagnostics in talks to raise $100 million in pre-IPO fundingmsn.com - April 17 at 9:52 AMGSK Announces FDA Acceptance of New Meningococcal Jab BLAmsn.com - April 17 at 9:52 AMGSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Yearsmsn.com - April 17 at 9:52 AMGSK says efficacy of its shingles vaccine remains high after yearsreuters.com - April 17 at 9:52 AM‘Kids need to breathe just like adults do:’ $35 price caps don’t apply to asthma meds young children need, doctors saymsn.com - April 17 at 9:52 AMCerity Partners LLC Buys 89,089 Shares of GSK plc (NYSE:GSK)marketbeat.com - April 17 at 5:34 AMGSK takes bold steps toward a healthier planettheglobeandmail.com - April 16 at 12:51 AMPipeline Moves: Pfizer’s flu vaccine approval chances rise after Phase III completionmsn.com - April 15 at 2:49 PMCommentary: Pharmacy benefit managers, not Big Pharma, responsible for high drug pricesbizjournals.com - April 15 at 8:24 AMInternational Assets Investment Management LLC Takes Position in GSK plc (NYSE:GSK)marketbeat.com - April 15 at 4:44 AMNeuberg Diagnostics plans to raise $100 mnmsn.com - April 12 at 3:29 PMIs GSK’s share price the best bargain in the FTSE 100?msn.com - April 11 at 7:41 AM“The last FTSE 100 stock I’d sell in a recession is…”msn.com - April 10 at 4:06 PM2 FTSE stocks I’d be willing to put 100% of my money into for passive income!uk.finance.yahoo.com - April 9 at 2:12 PMGSK, Pfizer-backed ViiV gets FDA okay for HIV drug for adolescentsmsn.com - April 8 at 12:33 PMAmericana Partners LLC Grows Stake in GSK plc (NYSE:GSK)marketbeat.com - April 8 at 8:46 AMFamily at war over death of vice-admiral on holidaythetimes.co.uk - April 7 at 9:25 PMChina Universal Asset Management Co. Ltd. Buys Shares of 54,345 GSK plc (NYSE:GSK)marketbeat.com - April 4 at 6:54 PMCureVac, GS Partner Release Data On Influenza Vaccine Studybenzinga.com - April 4 at 1:12 PMSanofi agrees to settle ~4K Zantac cancer lawsuits in all U.S. states except Delawaremsn.com - April 3 at 6:32 PMBiden and Senator Sanders to highlight efforts lower cost of asthma inhalersmsn.com - April 3 at 1:31 PMGSK plc (NYSE:GSK) Short Interest Updatemarketbeat.com - March 30 at 10:48 PMThe Nigerian Conundrum for Companies: Stay or Go?msn.com - March 30 at 8:08 PMThese Inhalers No Longer Cost More Than $35 Per Monthmsn.com - March 27 at 10:40 AMGSK (GSK) Stock Moves -0.09%: What You Should Knowmsn.com - March 27 at 5:39 AMDouglas Lane & Associates LLC Trims Stake in GSK plc (NYSE:GSK)marketbeat.com - March 25 at 3:56 PMWith 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional ownersfinance.yahoo.com - March 25 at 4:31 AMJTC Employer Solutions Trustee Ltd Trims Position in GSK plc (NYSE:GSK)marketbeat.com - March 23 at 3:41 PMCovid-19 anniversary: How have GSK and Astrazeneca fared since?msn.com - March 23 at 5:46 AMWellington Management Group LLP Sells 34,918 Shares of GSK plc (NYSE:GSK)marketbeat.com - March 22 at 4:18 AMDynamic Advisor Solutions LLC Increases Stock Position in GSK plc (NYSE:GSK)marketbeat.com - March 21 at 6:11 AMSosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Diseaseglobenewswire.com - March 20 at 8:01 PM Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address If you have $2,500 bucks… check this out (Ad)This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! Click here to unlock the Income Glitch training workshop for free. GSK Media Mentions By Week GSK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.200.33▲Average Medical News Sentiment GSK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼1710▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Regeneron Pharmaceuticals News Today Bristol-Myers Squibb News Today Zoetis News Today Vertex Pharmaceuticals News Today Sanofi News Today Takeda Pharmaceutical News Today Pfizer News Today Abbott Laboratories News Today Novartis News Today AstraZeneca News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingUrgent Nvidia WarningAltimetryHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
